fig7

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance

Figure 7. Doxorubicin-loaded albumin nanoparticles impaired A2780res proliferation. Clonogenic assay was performed at 3 h (A) and 20 h (B) of incubation with increasing concentration of DOX-NPs, GC DOX-NPs, and DOX solution. **P < 0.01 vs. DOX solution; §P < 0.05, §§P < 0.01 vs. GC DOX-NPs. DOX: doxorubicin hydrochloride; GC: glycol chitosan-coated; DOX-NPs: DOX-loaded nanoparticles

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/